Masimo

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Masimo and buy or sell other stocks, ETFs, and their options commission-free!

About MASI

Masimo develops and manufactures noninvasive monitoring technologies for healthcare settings. The company designs devices and sensors that measure physiological parameters such as oxygen saturation, pulse rate, respiration rate, and hemoglobin levels through signal processing and sensor-based platforms. 

CEO
Catherine M. Szyman, MBA
CEOCatherine M. Szyman, MBA
Employees
7,500
Employees7,500
Headquarters
Irvine, CALIFORNIA
HeadquartersIrvine, CALIFORNIA
Founded
1989
Founded1989
Employees
7,500
Employees7,500

MASI Key Statistics

Market cap
9.43B
Market cap9.43B
Price-Earnings ratio
123.41
Price-Earnings ratio123.41
Dividend yield
Dividend yield
Average volume
505.77K
Average volume505.77K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$179.99
52 Week high$179.99
52 Week low
$125.94
52 Week low$125.94

Stock Snapshot

With a market cap of 9.43B, Masimo(MASI) trades at $179.95. The stock has a price-to-earnings ratio of 123.41.

Masimo(MASI) stock opened on 2026-07-22 at —. The price climbed to — and dipped to —.

The Masimo(MASI)'s current trading volume is 0, compared to an average daily volume of 505.77K.

In the last year, Masimo(MASI) shares hit a 52-week high of $179.99 and a 52-week low of $125.94.

In the last year, Masimo(MASI) shares hit a 52-week high of $179.99 and a 52-week low of $125.94.

MASI News

The Motley Fool 18h
Danaher Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. Tuesday, July 21, 2026 at 8 a.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Rachel Vatnsdal President and Chief...

Danaher Q2 2026 Earnings Call Transcript
TipRanks 1d
Judge upholds Masimo’s $634M patent win over Apple Watch feature, BL reports

A federal judge has upheld a $634M jury verdict against Apple (AAPL) for infringing Masimo (MASI) patents related to Apple Watch heart rate monitoring technolog...

Simply Wall St 2d
Will Radius VSM Recalls and FDA Scrutiny Change Masimo's Innovation-Led Stability Narrative?

In February 2026, Masimo Corporation voluntarily initiated Class II recalls of several Radius VSM ECG and disposable blood pressure cuff products worldwide afte...

Will Radius VSM Recalls and FDA Scrutiny Change Masimo's Innovation-Led Stability Narrative?

More MASI News

Simply Wall St 4d
Will Masimo Integration and Bioprocessing Strength Change Danaher's Diagnostics-Driven Narrative?

Danaher recently benefited from optimism around its July 21 Q2 2026 earnings release, with analysts expecting modest revenue and earnings growth supported by st...

Will Masimo Integration and Bioprocessing Strength Change Danaher's Diagnostics-Driven Narrative?

People also own

Based on the portfolios of people who own MASI. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.